Use of convalescent plasma in hospitalized patients with COVID-19: case series | Zendy

Livia Hegerova | Zendy; Ted Gooley | Zendy; Kelly A. Sweerus | Zendy; Cynthia L. Maree | Zendy; Neil A. Bailey | Zendy; Megumi Bailey | Zendy; Vanessa Dunleavy | Zendy; Krish Patel | Zendy; Kirsten Alcorn | Zendy; Rebecca Haley | Zendy; Jill M. Johnsen | Zendy; Barbara A. Konkle | Zendy; Annamarie C. Lahti | Zendy; Morgan L. Alexander | Zendy; Jason D. Goldman | Zendy; Anne B. Lipke | Zendy; Sun-jung Lim | Zendy; Mark D. Sullivan | Zendy; John Pauk | Zendy; John M. Pagel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of convalescent plasma in hospitalized patients with COVID-19: case series

Author(s) -

Livia Hegerova,

Ted Gooley,

Kelly A. Sweerus,

Cynthia L. Maree,

Neil A. Bailey,

Megumi Bailey,

Vanessa Dunleavy,

Krish Patel,

Kirsten Alcorn,

Rebecca Haley,

Jill M. Johnsen,

Barbara A. Konkle,

Annamarie C. Lahti,

Morgan L. Alexander,

Jason D. Goldman,

Anne B. Lipke,

Sun-jung Lim,

Mark D. Sullivan,

John Pauk,

John M. Pagel

Publication year - 2020

Publication title -

blood

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.515

H-Index - 465

eISSN - 1528-0020

pISSN - 0006-4971

DOI - 10.1182/blood.2020006964

Subject(s) - convalescent plasma , covid-19 , medicine , clinical trial , series (stratigraphy) , intensive care medicine , virology , outbreak , paleontology , disease , infectious disease (medical specialty) , biology

Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research